Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-036565
Filing Date
2025-12-01
Accepted
2025-12-01 16:52:32
Documents
1
Period of Report
2025-11-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 4947
  Complete submission text file 0001437749-25-036565.txt   6360
Mailing Address C/O OLEMA PHARMACEUTICALS, INC. 780 BRANNAN STREET SAN FRANCISCO CA 94103
Business Address
BUTITTA CYNTHIA M (Reporting) CIK: 0001222082 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38079 | Film No.: 251540381

Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Issuer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)